Publications en collaboration avec des chercheurs de Clínica Universitaria de Navarra (34)

2024

  1. Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

    Journal of Physiology and Biochemistry

  2. The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies

    Annals of Surgery, Vol. 280, Núm. 1, pp. 46-55

2021

  1. Web-based formative assessment through clinical cases: role in pathophysiology teaching

    BMC Medical Education, Vol. 21, Núm. 1

2018

  1. Pneumatocele during sorafenib therapy: First report of an unusual complication

    Oncotarget, Vol. 9, Núm. 5, pp. 6652-6656

2017

  1. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

    Medicina Clinica, Vol. 149, Núm. 2, pp. 61-71

  2. Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation

    Annals of Transplantation, Vol. 22, pp. 141-147

  3. Evaluation of the rabbit liver by direct portography and contrast-enhanced computed tomography: anatomical variations of the portal system and hepatic volume quantification

    European Radiology Experimental, Vol. 1, Núm. 1

  4. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients

    Journal of Vascular and Interventional Radiology, Vol. 28, Núm. 11, pp. 1536-1542

2015

  1. Radioembolization with 90Y-microspheres for liver tumors

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 4, pp. 244-257

2014

  1. Acute generalized exanthematous pustulosis induced by sorafenib

    JAMA Dermatology

  2. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension

    HPB, Vol. 16, Núm. 3, pp. 243-249

  3. Radioembolization: Concepts and Procedures

    Therapeutic Nuclear Medicine (Springer), pp. 361-377

2013

  1. Lung cancer screening with low-radiation dose computed tomography after liver transplantation

    Annals of Transplantation, Vol. 18, Núm. 1, pp. 587-592

  2. Reply to: Downstaging to liver resection by radioembolization: A difficult to reach strategy?

    European Journal of Surgical Oncology

2012

  1. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

    European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601

2011

  1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

  2. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

    Liver Transplantation, Vol. 17, Núm. 4, pp. 402-408

  3. Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

    Hepatology, Vol. 54, Núm. 3, pp. 868-878

  4. Transarterial therapies for hepatocellular carcinoma

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 7, pp. 1057-1073

  5. Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells

    Journal of Hepatology, Vol. 55, Núm. 4, pp. 828-837